82 related articles for article (PubMed ID: 11118324)
1. N-Acetylcysteine counteracts erythrocyte alterations occurring in chronic obstructive pulmonary disease.
Straface E; Matarrese P; Gambardella L; Forte S; Carlone S; Libianchi E; Schmid G; Malorni W
Biochem Biophys Res Commun; 2000 Dec; 279(2):552-6. PubMed ID: 11118324
[TBL] [Abstract][Full Text] [Related]
2. Structural changes of the erythrocyte as a marker of non-insulin-dependent diabetes: protective effects of N-acetylcysteine.
Straface E; Rivabene R; Masella R; Santulli M; Paganelli R; Malorni W
Biochem Biophys Res Commun; 2002 Feb; 290(5):1393-8. PubMed ID: 11820776
[TBL] [Abstract][Full Text] [Related]
3. The red blood cell as a biosensor for monitoring oxidative imbalance in chronic obstructive pulmonary disease: an ex vivo and in vitro study.
Lucantoni G; Pietraforte D; Matarrese P; Gambardella L; Metere A; Paone G; Bianchi EL; Straface E
Antioxid Redox Signal; 2006; 8(7-8):1171-82. PubMed ID: 16910765
[TBL] [Abstract][Full Text] [Related]
4. Alterations in erythrocyte membrane protein composition in advanced non-small cell lung cancer.
Hernández-Hernández A; Rodríguez MC; López-Revuelta A; Sánchez-Gallego JI; Shnyrov V; Llanillo M; Sánchez-Yagüe J
Blood Cells Mol Dis; 2006; 36(3):355-63. PubMed ID: 16574438
[TBL] [Abstract][Full Text] [Related]
5. Long-term administration of N-acetylcysteine decreases hydrogen peroxide exhalation in subjects with chronic obstructive pulmonary disease.
Kasielski M; Nowak D
Respir Med; 2001 Jun; 95(6):448-56. PubMed ID: 11421501
[TBL] [Abstract][Full Text] [Related]
6. Oxalate-mediated oxidant-antioxidant imbalance in erythrocytes: role of N-acetylcysteine.
Bijarnia RK; Kaur T; Singla SK; Tandon C
Hum Exp Toxicol; 2009 Apr; 28(4):245-51. PubMed ID: 19734276
[TBL] [Abstract][Full Text] [Related]
7. Oral N-acetylcysteine attenuates pulmonary emphysema and alveolar septal cell apoptosis in smoking-induced COPD in rats.
Cai S; Chen P; Zhang C; Chen JB; Wu J
Respirology; 2009 Apr; 14(3):354-9. PubMed ID: 19341424
[TBL] [Abstract][Full Text] [Related]
8. Structural alterations in erythrocytes from patients with chronic obstructive pulmonary disease.
Santini MT; Straface E; Cipri A; Peverini M; Santulli M; Malorni W
Haemostasis; 1997; 27(4):201-10. PubMed ID: 9483175
[TBL] [Abstract][Full Text] [Related]
9. Chronic N-acetylcysteine administration prevents development of hypertension in N(omega)-nitro-L-arginine methyl ester-treated rats: the role of reactive oxygen species.
Rauchová H; Pechánová O; Kunes J; Vokurková M; Dobesová Z; Zicha J
Hypertens Res; 2005 May; 28(5):475-82. PubMed ID: 16156512
[TBL] [Abstract][Full Text] [Related]
10. [Changes of the activity and expression of gamma-glutamylcysteine synthetase in patients with chronic obstructive pulmonary disease].
Lin SD; Dai AG; Xu P
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):97-101. PubMed ID: 15854390
[TBL] [Abstract][Full Text] [Related]
11. N-acetylcysteine amide, a novel cell-permeating thiol, restores cellular glutathione and protects human red blood cells from oxidative stress.
Grinberg L; Fibach E; Amer J; Atlas D
Free Radic Biol Med; 2005 Jan; 38(1):136-45. PubMed ID: 15589382
[TBL] [Abstract][Full Text] [Related]
12. [The influence of n-acetylcysteine on chemiluminescence of granulocytes in peripheral blood of patients with chronic bronchitis].
Jankowska R; Passowicz-Muszyńska E; Medrala W; Banaś T; Marcinkowska A
Pneumonol Alergol Pol; 1993; 61(11-12):586-91. PubMed ID: 8148757
[TBL] [Abstract][Full Text] [Related]
13. Pathogenesis of cigarette smoke-induced chronic obstructive pulmonary disease and therapeutic effects of glucocorticoids and N-acetylcysteine in rats.
Xu L; Cai BQ; Zhu YJ
Chin Med J (Engl); 2004 Nov; 117(11):1611-9. PubMed ID: 15569474
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis and red blood cell echinocytosis: common features.
Chukhlovin AB
Scanning Microsc; 1996; 10(3):795-803; discussion 803-4. PubMed ID: 9813640
[TBL] [Abstract][Full Text] [Related]
15. Erdosteine enhances airway response to salbutamol in patients with mild-to-moderate COPD.
Dal Negro R; Visconti M; Trevisan F; Bertacco S; Micheletto C; Tognella S
Ther Adv Respir Dis; 2008 Oct; 2(5):271-7. PubMed ID: 19124377
[TBL] [Abstract][Full Text] [Related]
16. [Antioxidant treatment with N-acetylcysteine and vitamin C in patients with chronic bronchitis].
Lukas R; Schärling B; Schultze-Werninghaus G; Gillissen A
Dtsch Med Wochenschr; 2005 Mar; 130(11):563-7. PubMed ID: 15761783
[TBL] [Abstract][Full Text] [Related]
17. N-acetylcysteine prevents glucose/glucose oxidase-induced oxidative stress, mitochondrial damage and apoptosis in H9c2 cells.
Kumar S; Sitasawad SL
Life Sci; 2009 Mar; 84(11-12):328-36. PubMed ID: 19159629
[TBL] [Abstract][Full Text] [Related]
18. Effect of chronic N-acetylcysteine treatment on the development of spontaneous hypertension.
Pechánová O; Zicha J; Kojsová S; Dobesová Z; Jendeková L; Kunes J
Clin Sci (Lond); 2006 Feb; 110(2):235-42. PubMed ID: 16238546
[TBL] [Abstract][Full Text] [Related]
19. The effect of different treatment modalities on oxidative stress in COPD.
Kuleci S; Hanta I; Kocabas A; Canacankatan N
Adv Ther; 2008 Jul; 25(7):710-7. PubMed ID: 18592146
[TBL] [Abstract][Full Text] [Related]
20. New developments in the treatment of COPD: comparing the effects of inhaled corticosteroids and N-acetylcysteine.
van Overveld FJ; Demkow U; Górecka D; de Backer WA; Zielinski J
J Physiol Pharmacol; 2005 Sep; 56 Suppl 4():135-42. PubMed ID: 16204787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
